CORAL LABORATORIES Financial Statement Analysis
|
||
|
The Revenues of CORAL LABORATORIES have decreased by -25.31% YoY .
The Earnings Per Share (EPS) of CORAL LABORATORIES has decreased by -32.18 % YoY. |
||
CORAL LABORATORIES Last 5 Annual Financial Results
[BOM: 524506]
| Standalone | Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 |
|---|---|---|---|---|---|
| Revenues | ₹86 Cr | ₹115 Cr | ₹84 Cr | ₹78 Cr | ₹76 Cr |
| Expenses | ₹71 Cr | ₹89 Cr | ₹67 Cr | ₹74 Cr | ₹67 Cr |
| Operating Profit (Excl OI) | ₹15 Cr | ₹26 Cr | ₹16 Cr | ₹3.81 Cr | ₹8.21 Cr |
| Other Income | ₹9.90 Cr | ₹9.11 Cr | ₹6.63 Cr | ₹6.90 Cr | ₹4.81 Cr |
| Interest | ₹0.17 Cr | ₹0.10 Cr | ₹0.00 Cr | ₹0.34 Cr | ₹0.14 Cr |
| Depreciation | ₹2.14 Cr | ₹2.01 Cr | ₹1.98 Cr | ₹2.18 Cr | ₹1.99 Cr |
| Profit Before Tax | ₹23 Cr | ₹32 Cr | ₹21 Cr | ₹8.23 Cr | ₹12 Cr |
| Profit After Tax | ₹16 Cr | ₹24 Cr | ₹16 Cr | ₹6.45 Cr | ₹9.05 Cr |
| Earnings Per Share (Rs) | ₹45.85 | ₹67.61 | ₹44.19 | ₹18.04 | ₹25.32 |
| PAT Margin (%) | 19.07 | 21.00 | 18.87 | 8.25 | 11.96 |
| ROE(%) | 7.98 | 12.76 | 9.50 | 4.15 | 6.18 |
| ROCE(%) | 11.14 | 17.04 | 12.48 | 5.41 | 7.87 |
| Total Debt/Equity(x) | 0.02 | 0.02 | 0.00 | 0.00 | 0.04 |
Key Financials |
||
| Market Cap | : | ₹ 175.0 Cr |
| Revenue (TTM) | : | ₹ 96.7 Cr |
| Net Profit(TTM) | : | ₹ 19.2 Cr |
| EPS (TTM) | : | ₹ 53.4 |
| P/E (TTM) | : | 9.1 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| CORAL LABORATORIES | -6.5% | -13.5% | 2.7% |
| SUN PHARMACEUTICAL INDUSTRIES | 0.7% | -0.3% | 3.2% |
| DIVIS LABORATORIES | 4% | 8.9% | 54.1% |
| TORRENT PHARMACEUTICALS | 3.6% | -0.5% | 28.8% |
| CIPLA | 3.2% | 5% | -11.9% |
| DR REDDYS LABORATORIES | 2.5% | 13.6% | 9.4% |
| MANKIND PHARMA | 2.9% | 2.2% | 1.3% |
| LUPIN | 0.9% | 0.3% | 2.8% |
| ZYDUS LIFESCIENCES | 0.3% | 4.5% | 23.7% |
CORAL LABORATORIES Revenues
[BOM: 524506]
| Y-o-Y | -25.31 % |
| 5 Yr CAGR | 3.24 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2026 | ₹86 Cr | -25.31 | |
| Mar2025 | ₹115 Cr | 37.47 | |
| Mar2024 | ₹84 Cr | 7.09 | |
| Mar2023 | ₹78 Cr | 3.32 | |
| Mar2022 | ₹76 Cr | - | |
CORAL LABORATORIES Operating Profit
[BOM: 524506]
| Y-o-Y | -42.02 % |
| 5 Yr CAGR | 16.66 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹15 Cr | -42.02 | |
| Mar2025 | ₹26 Cr | 61.58 | |
| Mar2024 | ₹16 Cr | 326.00 | |
| Mar2023 | ₹3.81 Cr | -53.59 | |
| Mar2022 | ₹8.21 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | -22.39 % |
| 5 Yr CAGR | 13.00 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2026 | 17.71% | -22.39 | |
| Mar2025 | 22.82% | 17.57 | |
| Mar2024 | 19.41% | 297.75 | |
| Mar2023 | 4.88% | -55.06 | |
| Mar2022 | 10.86% | - | |
CORAL LABORATORIES Profit After Tax
[BOM: 524506]
| Y-o-Y | -32.19 % |
| 5 Yr CAGR | 16.00 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2026 | ₹16 Cr | -32.19 | |
| Mar2025 | ₹24 Cr | 52.99 | |
| Mar2024 | ₹16 Cr | 144.98 | |
| Mar2023 | ₹6.45 Cr | -28.75 | |
| Mar2022 | ₹9.05 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | -9.19 % |
| 5 Yr CAGR | 12.37 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2026 | 19.07 % | -9.19 | |
| Mar2025 | 21 % | 11.29 | |
| Mar2024 | 18.87 % | 128.73 | |
| Mar2023 | 8.25 % | -31.02 | |
| Mar2022 | 11.96 % | - | |
CORAL LABORATORIES Earnings Per Share (EPS)
[BOM: 524506]
| Y-o-Y | -32.18 % |
| 5 Yr CAGR | 16.00 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2026 | ₹46 | -32.18 | |
| Mar2025 | ₹68 | 53.00 | |
| Mar2024 | ₹44 | 144.96 | |
| Mar2023 | ₹18 | -28.75 | |
| Mar2022 | ₹25 | - | |
CORAL LABORATORIES Return on Capital Employed (ROCE)
[BOM: 524506]
| Y-o-Y | -34.62 % |
| 5 Yr CAGR | 9.08 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2026 | 11.14% | -34.62 | |
| Mar2025 | 17.04% | 36.54 | |
| Mar2024 | 12.48% | 130.68 | |
| Mar2023 | 5.41% | -31.26 | |
| Mar2022 | 7.87% | - | |
CORAL LABORATORIES Share Price vs Sensex
| Current Share Price | : | ₹486.2 |
| Current MarketCap | : | ₹ 175.0 Cr |
| Updated EOD on | : | Nov 04,2026 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CORAL LABORATORIES | -6.5% |
-13.5% |
2.7% |
| SENSEX | 5.5% |
7.5% |
-8.7% |
CORAL LABORATORIES related INDICES
No BSE index found!
No NSE index found
You may also like the below Video Courses
FAQ about CORAL LABORATORIES Financials
How the annual revenues of CORAL LABORATORIES have changed ?
The Revenues of CORAL LABORATORIES have decreased by -25.31% YoY .
How the Earnings per Share (EPS) of CORAL LABORATORIES have changed?
The Earnings Per Share (EPS) of CORAL LABORATORIES has decreased by -32.18 % YoY .
Check out Intrinsic Value of Peers of CORAL LABORATORIES
Compare Stock Analytics of Peers of CORAL LABORATORIES
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs TORRENT PHARMACEUTICALS LTD
CIPLA LTD vs DR REDDYS LABORATORIES LTD vs
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs TORRENT PHARMACEUTICALS LTD
CIPLA LTD vs DR REDDYS LABORATORIES LTD vs
